attach research report excerpt
research report written
entir broker partner auerbach
grayson auerbach grayson
auerbach grayson distributing/provid
research report consider
made modest upgrad model provid ep upgrad
forecast period
note materi increas re-suppli sale activ last month
suggest technolog becom profit hme
custom mask price expect equalis us centr
medicar medicaid servic enact price chang re-suppli
program off-set price pressur utilis market share gain
platform product cycl sixth year new flow gener platform launch
could refresh price point offer enhanc connect
separ new fund chang hit softwar custom
skill nurs facil homecar hospic provid expect chang
drive adopt enterpris softwar system includ resm matrix brightre
healthcarefirst new fund regim also offer favour reimburs
outcom patient requir ventil respiratori care devic
resm astral stellar vpap devic could benefit
upgrad price target base dcf analysi maintain
overweight call
risk advers reimburs cut sleep apnoea fund product
launch competitor fx volatil catalyst market share gain
singl payment amount competit bid round us summer
maintain overweight rate upgrad price
target earn upgrad relat core busi
mask re-suppli program potenti new flow gener platform
launch could logic defenc head new round fund
chang separ skill nurs homecar
hospic custom grappl fund chang
identifi market growth share opportun develop resm
softwar solut medic devic busi life support non-
earn upgrad softwar mask respiratori care devic
portfolio made modest upgrad model provid ep
upgrad forecast period
mask-resuppli technolog launch logic defenc
ahead competit bid round note materi increas
re-suppli sale activ last month suggest technolog
becom profit hme custom mask price
expect equalis us centr medicar medicaid
servic enact price chang re-suppli program
off-set price pressur utilis market share gain
platform product cycl sixth year new flow gener platform launch
could refresh price point offer enhanc connect
reimburs chang long-term post-acut care drive softwar
ventil respiratori care sale separ new fund
chang hit softwar custom skill nurs
facil homecar hospic provid expect chang drive
adopt enterpris softwar system includ resm matrix brightre
healthcarefirst new fund regim also offer favour
reimburs outcom patient requir ventil respiratori
care devic resm astral stellar vpap devic could benefit
valuat upgrad price target base dcf analysi
maintain overweight call
risk catalyst
risk advers reimburs cut sleep apnoea fund product
launch competitor fx volatil
earn end announc singl payment amount
share issu
analyst share compani n/a
issu wilson advisori stockbrok limit wilson abn australian financi servic licenc particip asx group
read conjunct disclosur disclaim report import disclosur regard compani subject report
explan recommend found end document
health equip suppli
profit loss
fund equiti
fund debt
fund cash
health equip suppli
insuper posit global sleep therapi industri industry-level penetr
usa obstruct sleep apnea osa market like less leav long runway
growth enhanc osa awar diagnosi support new patient growth
win major new patient start assess hold
us flow gener market year product cycl associ connect
care softwar solut market penetr european row market still
like jurisdict express reimburs prefer
connect medic devic like take market share global
re-suppli program cement us market share mask ahead new
resili resm us mask revenu growth least three anteced factor first
prodigi gain flow gener market share favour mask new patient
set-up also maintain high activ releas new mask regular
cadenc includ entri top head categori last note materi
acceler re-suppli activ last month particularli within larger hme
account forthcom competit bid round expect put
price pressur mask manufactur autom re-suppli
convinc hme approach sell mask profit busi re-
suppli becom autom patient payer may fewer point
reason hme offer patient altern brand set
equip activ re-suppli may therefor off-set price pressur
volum market share doj investig re-suppli free trial settl
end admiss wrongdo may see manufactur push harder
brand loyalti mask
launch may see launch new flow gener platform next
year time could advantag refresh price point ahead
term innov expect see greater connect across respiratori
devic portfolio life support pressur support bi-level portabl oxygen integr
devic relev enterpris softwar solut matrix healthcarefirst may
stimulu market share medic devic categori
softwar busi benefit market share gain forecast period driven
patient-direct payment reform us skill nurs facil snf industri
oper new reimburs regim patient-driven payment model pdpm
sinc octob us homecar hospic industri face similar chang
januari patient-driven group model pdgm regim replac fee
servic payment model fix payment set basi patient diagnos
admiss assess industri yet adopt softwar
solut streamlin admiss optimis payment manag cost deliv
care obviou market growth share opportun avail
higher acuiti patient set driver ventil respiratori care
due favour reimburs corollari pdpm/pdgm chang
set incentivis take sicker patient note respiratori therapi
ventil care provid consider financi benefit snf pdpm model
ventil tracheostomi care automat place new resid highest
reimburs case-mix group nurs compon pdpm anecdot
understand snf group move includ respiratori ventil care
busi also requir good clinic cost monitor optimis earn per
resid see pdpm potenti driver astral life support ventil
health equip suppli
chang forecast
made modest chang model increas saa softwar respiratori
medic devic sale inclus ep chang
tabl chang model estim
health equip suppli
resm inc develop manufactur sell medic devic treatment sleep disord breath respiratori
diseas recent year compani built acquir way lead posit enterpris softwar system appeal out-of-
hospit healthcar provid includ skill nurs homecar hospic
maintain overweight rate upgrad price target earn upgrad relat core busi
mask re-suppli program potenti new flow gener platform launch could logic defenc head new round fund
chang separ skill nurs homecar hospic custom grappl fund chang
identifi market growth share opportun develop softwar solut medic devic busi life support non-
grow easier access diagnosi sleep disord
rel short product cycl refresh price point
new devic area
gross margin expos fx aud sgd vs usd
 sg typic net sale
product mix higher-end apap ventil bilevel mask
higher gross margin
competit intensifi low-end cpap market
net debt averag next month impli net
leverag
restor sustain industri us devic volum flow
increment margin benefit mix shift apap
risk view
increas competit price point
slower-than-expect market growth particularli challeng
price reimburs challeng usa elsewher
relat poor complianc cpap
health equip suppli
disclaim disclosur
